ID   TUBO [Mouse mammary tumor]
AC   CVCL_2A33
SY   Turin-Bologna
DR   EFO; EFO_0006306
DR   Millipore; SCC222
DR   Wikidata; Q54973345
RX   PubMed=11046045;
RX   PubMed=25179116;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB-neuT transgenic.
ST   Source(s): Millipore=SCC222
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 24.2,29
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 25
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
RX   PubMed=11046045; DOI=10.4049/jimmunol.165.9.5133;
RA   Rovero S., Amici A., Di Carlo E., Bei R., Nanni P., Quaglino E.,
RA   Porcedda P., Boggio K., Smorlesi A., Lollini P.-L., Landuzzi L.,
RA   Colombo M.P., Giovarelli M., Musiani P., Forni G.;
RT   "DNA vaccination against rat her-2/Neu p185 more effectively inhibits
RT   carcinogenesis than transplantable carcinomas in transgenic BALB/c
RT   mice.";
RL   J. Immunol. 165:5133-5142(2000).
//
RX   PubMed=25179116; DOI=10.1186/1471-2407-14-647; PMCID=PMC4161915;
RA   Song H., Kim T.O., Ma S.Y., Park J.-H., Choi J.-H., Kim J.-H.,
RA   Kang M.S., Bae S.K., Kim K.H., Kim T.H., Seo S.-K., Choi I.W.,
RA   Song G.A., Mortenson E.D., Fu Y.-X., Park S.;
RT   "Intratumoral heterogeneity impacts the response to anti-neu antibody
RT   therapy.";
RL   BMC Cancer 14:647.1-647.12(2014).
//